ALX ONCOLOGY HOLDINGS INC (ALXO) Stock Balance Sheet
NASDAQ:ALXO • US00166B1052
Current stock price
1.67 USD
-0.01 (-0.6%)
At close:
1.65 USD
-0.02 (-1.2%)
After Hours:
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 434.20M | |||
| Cash Equivalents | N/A | 22.41M | 48.80M | 363.70M | N/A | |||
| Marketable Securities | N/A | 160.33M | 217.40M | N/A | N/A | |||
| Receivables | 1.34M | 1.00M | N/A | N/A | 0.00 | |||
| Other Current Assets | 5.26M | 4.92M | 4.80M | 3.40M | 1.80M | |||
| Total Current Assets | 134.00M | 189.00M | 271.00M | 367.00M | 436.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.63M | 11.00M | 9.80M | 3.40M | 100.00K | |||
| Investments And Advances | 3.52M | 35.00M | 16.70M | N/A | N/A | |||
| Other Non-Current Assets | 200.00K | 7.58M | 9.00M | 9.80M | 0.00 | |||
| Total Non-Current Assets | 14.00M | 54.00M | 35.50M | 13.20M | 100.00K | |||
| TOTAL ASSETS | 148.00M | 243.00M | 306.50M | 380.20M | 436.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.40M | 730.00K | 300.00K | 400.00K | N/A | |||
| Accrued Expenses | 12.00M | 26.00M | 19.80M | 11.10M | 6.00M | |||
| Accounts Payable | 4.50M | 8.59M | 8.10M | 3.80M | 0.00 | |||
| Other Current Liabilities | 660.00K | 630.00K | 200.00K | N/A | 200.00K | |||
| Total Current Liabilities | 19.00M | 36.00M | 28.30M | 15.30M | 6.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 11.00M | 11.00M | 9.40M | 300.00K | 0.00 | |||
| Other Non-Current Liabilities | 4.49M | 5.63M | 5.30M | 1.60M | 0.00 | |||
| Total Non-Current Liabilities | 15.00M | 17.00M | 14.70M | 1.80M | 0.00 | |||
| TOTAL LIABILITIES | 34.00M | 53.00M | 43.00M | 17.10M | 6.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -621.00M | -486.00M | -325.50M | -202.00M | -118.50M | |||
| Additional Paid In Capital | 734.00M | 676.00M | 589.70M | 565.00M | 548.30M | |||
| Common Shares | 50.00K | 50.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 280.00K | 260.00K | -800.00K | N/A | N/A | |||
| Shares Outstanding | 53.00M | 50.00M | 40.90M | 40.60M | 39.80M | |||
| Tangible Book Value per Share | N/A | 3.80 | 6.44 | 8.94 | 10.80 | |||
| Total Shareholders' Equity | 114.00M | 190.00M | 263.50M | 363.00M | 429.80M | |||
| TOTAL LIABILITIES AND EQUITY | 148.00M | 243.00M | 306.50M | 380.20M | 436.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.10 | 0.06 | 0.04 | 0.00 | N/A | |||
| Current Ratio | 7.05 | 5.25 | 9.58 | 23.99 | 70.32 | |||
| Return On Assets (ROA) | -91.22% | -66.26% | -40.29% | -21.95% | -11.68% | |||
| Return On Equity (ROE) | -118.42% | -84.74% | -46.86% | -22.99% | -11.85% | |||
All data in USD , ROIC based on taxRate of 0.21